There is a well documented association between coeliac disease and reduced bone mineral density (BMD). Osteopenia and osteoporosis are both preventable and treatable. There are clear clinical recommendations available for measuring BMD in subgroups of patients with coeliac disease. However, it is suspected that within the practice population these standards are not being achieved. This suspicion is based on routine clinical encounters with patients with coeliac disease.
Get full access to this article
View all access options for this article.
References
1.
American Gastroenterological Association medical position statement: celiac sprue. Gastroenterology (2001) 120: p. 1522–5.
2.
British Society of Gastroenterology. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease (2000) Accessed via www.bsg.org.uk/pdf_word_docs/osteo.pdf [date last accessed 30.03.2009].
3.
British Society of Gastroenterology. Guidelines for the management of patients with coeliac disease (2002) Accessed via www.bsg.org.uk/pdf_word_docs/coeliac.doc [date last accessed 30.03.2009].
4.
CiclitiraP.Interim guidelines for the management of patients with coeliac disease. British Society of Gastroenterology (2002) Accessed via www.bsg.org.uk/bsgdisp1.php?id=c9c5177d2b91e3228066 [date last accessed 30.03.2009].
5.
RangnekarA.S.CheyW.D.(Commentators) Review: tissue transglutaminase test is almost as accurate as endomysial antibody test for diagnosis of coeliac disease. Evidence-Based Medicine (2006) 11: p. 25.
6.
GibsonN.E.IgA endomyseal and transglutaminase antibodies had high specificity for diagnosis of coeliac disease. Evidence-Based Medicine (2006) 11: p. 25.
7.
National Institute for Health and Clinical Excellence (NICE). CG86 Coeliac disease—recognition and assessment of coeliac disease. Accessed via guidance.nice.org.uk/index.jsp?action=folder&o=44357 [date last accessed 30.03.2009].
8.
National Institute for Health and Clinical Excellence (NICE). TA160 Osteoporosis—primary prevention: quick reference guide. Accessed via www.nice.org.uk/nicemedia/pdf/TA160quickrefguide.pdf [date last accessed 30.03.2009].
SblatteroD.BertiI.TrevisiolC.Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. American Journal of Gastroenterology (2000) 95: p. 1253–7.
